HK1008495A1 - Chlamydia vaccines - Google Patents

Chlamydia vaccines

Info

Publication number
HK1008495A1
HK1008495A1 HK98109493A HK98109493A HK1008495A1 HK 1008495 A1 HK1008495 A1 HK 1008495A1 HK 98109493 A HK98109493 A HK 98109493A HK 98109493 A HK98109493 A HK 98109493A HK 1008495 A1 HK1008495 A1 HK 1008495A1
Authority
HK
Hong Kong
Prior art keywords
chlamydia vaccines
chlamydia
vaccines
immunostimulants
mpl
Prior art date
Application number
HK98109493A
Other languages
English (en)
Inventor
Jean-Paul Prieels
Moncef Mohamed Slaoui
Jean-Francois Maisonneuve
Vincent Verlant
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of HK1008495A1 publication Critical patent/HK1008495A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
HK98109493A 1995-04-03 1998-07-28 Chlamydia vaccines HK1008495A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9506863.1A GB9506863D0 (en) 1995-04-03 1995-04-03 Vaccines
PCT/EP1996/001463 WO1996031236A1 (en) 1995-04-03 1996-04-01 Chlamydia vaccines

Publications (1)

Publication Number Publication Date
HK1008495A1 true HK1008495A1 (en) 1999-05-14

Family

ID=10772426

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98109493A HK1008495A1 (en) 1995-04-03 1998-07-28 Chlamydia vaccines

Country Status (23)

Country Link
EP (1) EP0820304B1 (xx)
JP (2) JPH11503142A (xx)
KR (1) KR19980703666A (xx)
CN (1) CN1185740A (xx)
AT (1) ATE193974T1 (xx)
AU (1) AU700548B2 (xx)
BR (1) BR9604853A (xx)
CA (1) CA2215520C (xx)
CZ (1) CZ313497A3 (xx)
DE (1) DE69608959T2 (xx)
DK (1) DK0820304T3 (xx)
ES (1) ES2149466T3 (xx)
GB (1) GB9506863D0 (xx)
GR (1) GR3033764T3 (xx)
HK (1) HK1008495A1 (xx)
HU (1) HUP9801572A3 (xx)
NO (1) NO974561L (xx)
NZ (1) NZ306443A (xx)
PL (1) PL322620A1 (xx)
PT (1) PT820304E (xx)
TR (1) TR199701113T1 (xx)
WO (1) WO1996031236A1 (xx)
ZA (1) ZA962616B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9626864D0 (en) * 1996-12-24 1997-02-12 Smithkline Beecham Biolog Vaccine
US7459524B1 (en) 1997-10-02 2008-12-02 Emergent Product Development Gaithersburg Inc. Chlamydia protein, sequence and uses thereof
US6306404B1 (en) 1998-07-14 2001-10-23 American Cyanamid Company Adjuvant and vaccine compositions containing monophosphoryl lipid A
GB9819898D0 (en) * 1998-09-11 1998-11-04 Smithkline Beecham Plc New vaccine and method of use
US20020061848A1 (en) * 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US6635261B2 (en) 1999-07-13 2003-10-21 Wyeth Holdings Corporation Adjuvant and vaccine compositions containing monophosphoryl lipid A
US20010048927A1 (en) 2000-02-01 2001-12-06 Richard Stephens Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia
US7105171B2 (en) 2002-03-07 2006-09-12 The Regents Of The University Of California Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
US8541007B2 (en) 2005-03-31 2013-09-24 Glaxosmithkline Biologicals S.A. Vaccines against chlamydial infection
EA201001322A1 (ru) * 2005-03-31 2011-02-28 Глаксосмитклайн Байолоджикалс С.А. Вакцины против хламидиоза
ES2788728T3 (es) 2010-05-28 2020-10-22 Spixia Biotechnology Ab Antígeno de la MOMP quimérica, método y uso
CN113940994B (zh) * 2021-11-09 2023-09-15 南华大学 壳聚糖-Pickering乳液白细胞介素12佐剂体系的制备方法及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9000207A (xx) * 1990-01-29 1991-08-16 Duphar Int Res
JP3183665B2 (ja) * 1990-12-10 2001-07-09 エントルメド インコーポレーテッド コレステロール過剰血症およびアテローム性動脈硬化を防止するためのコレステロールに体するワクチン
CH682455A5 (fr) * 1991-07-25 1993-09-30 Serge Liotet Composition vaccinale.
JPH05339169A (ja) * 1992-03-03 1993-12-21 Dai Ichi Seiyaku Co Ltd 経口ワクチン
ES2143716T3 (es) * 1992-06-25 2000-05-16 Smithkline Beecham Biolog Composicion de vacuna que contiene adyuvantes.

Also Published As

Publication number Publication date
HUP9801572A3 (en) 1999-04-28
BR9604853A (pt) 1998-06-16
DK0820304T3 (da) 2000-08-28
JPH11503142A (ja) 1999-03-23
PT820304E (pt) 2000-11-30
ATE193974T1 (de) 2000-07-15
GR3033764T3 (en) 2000-10-31
NO974561D0 (no) 1997-10-02
CN1185740A (zh) 1998-06-24
HUP9801572A2 (hu) 1998-10-28
CA2215520A1 (en) 1996-10-10
ZA962616B (en) 1996-11-27
WO1996031236A1 (en) 1996-10-10
PL322620A1 (en) 1998-02-02
NO974561L (no) 1997-11-26
AU700548B2 (en) 1999-01-07
CA2215520C (en) 2008-01-22
CZ313497A3 (cs) 1998-03-18
MX9707638A (es) 1998-06-28
TR199701113T1 (xx) 1998-03-21
GB9506863D0 (en) 1995-05-24
ES2149466T3 (es) 2000-11-01
NZ306443A (en) 1999-02-25
EP0820304A1 (en) 1998-01-28
DE69608959T2 (de) 2000-11-16
DE69608959D1 (de) 2000-07-27
KR19980703666A (ko) 1998-12-05
AU5499996A (en) 1996-10-23
EP0820304B1 (en) 2000-06-21
JP2007308508A (ja) 2007-11-29

Similar Documents

Publication Publication Date Title
GB2322801B (en) Vaccine compositions for intranasal administration comprising chitosan and use thereof
ES2140076T3 (es) Vacunas que contienen una saponina y un esterol.
GB9506863D0 (en) Vaccines
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
WO1997005899A3 (en) Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
ATE249841T1 (de) Immunogene zubereitungen
WO1997018790A3 (en) Therapeutic and diagnostic agents for the treatment of microbial infections
AU7237391A (en) Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine
AU5289193A (en) New influenza virus peptides, diagnostics and vaccines
WO1998040097A3 (en) Bovine respiratory and enteric coronavirus as a vaccine
AU1681095A (en) Hydrophilic signal oligopeptides and methods of therapeutic use
AU4450696A (en) Enhanced immunogenic vaccine
AU3552797A (en) Vaccine preparations
AU3755999A (en) Proteins that direct the secretion of virulence proteins and vaccines comprisingthem
AU1825895A (en) Retroviral vaccines, vaccination and immune-therapy for retroviral infections
AU5520796A (en) Peptide-based vaccine against papillomavirus infection
GR3026385T3 (en) Temporary inactivated benzoyl peroxide, process for its preparation and use thereof
CS8904172A1 (en) Nonspecific bacterial vaccine for prevention and therapy of bacterial,fungal and viral infections
MX9100273A (es) Vacunas conjugadas en forma conjunta que comprenden proteina inmunogenica,peptidos relacionados con el hiv y porciones anionicas
ZA915626B (en) Coconjugate vaccines comprising immunogenic protein,hiv related peptides,and anionic moieties
ECSP961731A (es) Vacunas

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20040330

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)